基金
全军十一五医药卫生专项科研基金(06Z051)
参考文献10
-
1Doverty M, White JM, Somogyi AA, et al. Hyperalgesic responses in methadone maintenance patients. Pain,2001,90:91-96.
-
2Hood DD, Curry R, Eisenach JC. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with eapsaicin-induced hyperalgesia. Anesth Analg, 2003,97 : 810-815.
-
3Koppert W, Sittl R, ,Scheuber K, et al. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S- ketamine and clonidine in humans. Anesthesiology, 2003,99:152-159.
-
4Cepeda MS, Alvarez H, Morales O, et al. Addition of ultralow dose naloxone to postoperative morphine PCA: Unchanged analgesia and opioid requirement but decreased incidence of opioid side effects. Pain,2004,107:41-46.
-
5Gardell LR, Wang R, Burgess SE, et al. Sustained morphine exposure induces a spinal dynorpbindependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosei, 2002,22:6747.
-
6Moran TD, Smith PA. Morphine-3beta-D-glueuronide suppresses inhibitory synaptic transmission in rat suhstantia gelatinosa. J Pharmacol Exp Ther, 2002, 302:568-576.
-
7Sweitzer SM, Wong SME, Tjolsen A, et al. Exaggerated nocieeptive responses on morphine withdrawal: roles of protein kinase C epsilon, and gamma. Pain, 2004,110 : 281-289.
-
8Vanderah TW, Gardell LR, Burgess SE, et al. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci, 2000,20 : 7074-7079.
-
9Li X, Clark JD: Hyperalgesia during opioid abstinence: mediation by glutamate and substance P. Anesth Analg,2002,95 : 979-984.
-
10Liang DY, Liao G, Wang J, et al. A genetic analysis of opioid-in duced hyperalgesia in mice. Anesthesiology,2006,104:1054-1062.
同被引文献63
-
1刘端祺.解说“三阶梯止痛”[J].抗癌之窗,2010(3):20-21. 被引量:2
-
2冯素文,来军,袁芳,赵志妹.影响妇科癌症患者家属生活质量的相关因素研究[J].中华护理杂志,2006,41(5):402-404. 被引量:62
-
3PROSPECTworking group PROSPECTprocedure specific postoperative pain management. Aceessed at www. postoppain, org, September 14th 2011.
-
4Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast -track surgery. Ann Surg, 2008, 248 (2) : 189-198.
-
5Lassen K, Soop M, Nygren J, et al. Enhanced Recovery After Surgery (ERAS) Group. Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. Arch Surg, 2009, 144 (10): 961-969.
-
6Neuss H, Raue W, Muller V, et al. Effects of cyclooxygenase inhibition on anastomotic healing following large bowel resection in a rabbit model-a randomized, blinded, placebo-controlled trial. Int J Colorectal Dis, 2009, 24(5): 551-557.
-
7Cahill RA, Sheehan KM, Scanlon RW, et al. Effect of diclofenac on cyclooxygenase-2 levels and early breaking strength of experimental colonic anastomoses and skin incisions. Eur Surg Res, 2011, 46(1): 26-31.
-
8Klein M, Andersen LP, Harvald T, et al. Increased risk of anastomotic leakage with diclofenac treatment after laparoscopic colorectal surgery. Dig Surg, 2009, 26( 1 ) : 27-30.
-
9Kurahara K, Matsumoto T, Iida M. Clinical features of non-steroidal anti-inflammatory drug-induced colopathy. Nippon Rinsho, 2007, 65( 10): 1875-1878.
-
10Sinatra R. Role of COX-2 inhibitors in the evolution of acute pain management. J Pain Symptom Manage, 002, 24 (Suppl): S18- $27.
引证文献6
-
1嵇承栋,熊源长.非甾体抗炎药物对结直肠吻合口愈合影响的研究进展[J].国际麻醉学与复苏杂志,2013,34(1):62-65.
-
2薛钧,刘晓铭,刘晶煜,朱婷,李文娟,陈梅林.809例晚期癌痛患者阿片耐受性及量化分析方法研究[J].中国疼痛医学杂志,2014,20(4):236-240. 被引量:8
-
3郑剑菁,王铃.结合疼痛管理的护理干预对晚期肺癌癌痛患者生活质量的影响[J].齐齐哈尔医学院学报,2017,38(24):2959-2960. 被引量:10
-
4楼洁,邵瑾.氢吗啡酮对瑞芬太尼复合麻醉所致术后痛觉过敏的预防作用研究[J].中国基层医药,2018,25(9):1167-1170. 被引量:2
-
5陆彦霓,汤晓青,沈丽达.OPRM1(A118G)基因多态性对阿片类药物镇痛效应影响的研究进展[J].现代肿瘤医学,2018,26(9):1477-1480. 被引量:8
-
6吕亚青.超大剂量吗啡自控镇痛治疗难治性癌痛1例[J].医药导报,2019,38(2):265-266.
二级引证文献28
-
1李霞.临床护理干预对晚期肺癌患者疼痛及生活质量的影响[J].中国农村卫生,2020,0(3):65-65.
-
2马大飞,岳济民.经硬膜外腔注入低浓度罗哌卡因用于阑尾炎手术中的镇痛效果研究[J].湖南师范大学学报(医学版),2020(5):169-172.
-
3孔令霞.个性化疼痛护理对晚期肺癌患者心理状态及生活质量的影响[J].医学信息,2022,35(S01):149-151.
-
4李颖,李欣,姜达,张增叶,董倩.癌痛规范化治疗的意义探讨[J].中国肿瘤临床,2015,42(12):594-599. 被引量:19
-
5曹颖,栾海波,梁春慧.北京市门头沟区医院癌症疼痛诊疗质控情况分析[J].临床荟萃,2016,31(8):901-904. 被引量:2
-
6张燕燕,康瑞.非小细胞肺癌脑转移致顽固性头痛的临床治疗进展[J].实用医药杂志,2016,33(8):743-745. 被引量:1
-
7陆彦霓,汤晓青,沈丽达.OPRM1(A118G)基因多态性对阿片类药物镇痛效应影响的研究进展[J].现代肿瘤医学,2018,26(9):1477-1480. 被引量:8
-
8莫港英,苏文智,王道笃,江小好,郑云.癌痛规范化治疗联合超声药物离子导入治疗癌痛的临床研究[J].护理实践与研究,2018,15(11):126-128. 被引量:5
-
9郑孝振,毛珊珊,任益锋,韩箫笛,宋俊杰.脊髓背角NMDA受体NR2B亚基对舒芬太尼耐受形成的影响研究[J].分子诊断与治疗杂志,2018,10(6):372-377. 被引量:2
-
10滕海霞.疼痛管理对肿瘤晚期安宁疗护患者生活质量的影响分析[J].系统医学,2019,4(17):163-165. 被引量:6
-
1张志谦,赵宝明,耿学斯.痛觉敏化的分子生物学研究进展[J].上海医学,2012,35(10):900-903. 被引量:8
-
2刘芳芳,田蜜,纪木火,吴智方,金利,李伟彦.脊髓CCR-8表观遗传学调控在小鼠切口痛模型痛觉敏化的作用[J].临床麻醉学杂志,2014,30(5):482-484. 被引量:3
-
3李伟,刘敏,孙伟,王光春,车建平,许云飞,彭波,郑军华.还原型谷胱甘肽联合美洛昔康在大鼠睾丸扭转损伤修复中的治疗作用[J].中华实验外科杂志,2013,30(12):2750-2750.
-
4新患答疑[J].抗癌,2007(4):25-26.
-
5石文汇,张宗旺.钾-氯离子协同转运体2参与痛觉敏化形成的研究进展[J].国际麻醉学与复苏杂志,2015,36(2):170-173. 被引量:1
-
6“用好国家每一分钱,每一片药,真正让每个家庭受益”——山西为育龄妇女增补叶酸预防新生儿神经管出生缺陷[J].全科护理,2009,7(18):1686-1686.
-
7周会兰,蒋晓莲.分散注意力控制疼痛的研究进展[J].继续医学教育,2007,21(14):12-15. 被引量:9
-
8黄娅琴,雷卫平,孙建良.N-甲基-D-天冬氨酸受体NR2B亚单位在神经病理性疼痛中的作用及其研究进展[J].国际麻醉学与复苏杂志,2015,36(10):933-936. 被引量:2
-
9江龙,李森,王莉,洪有建,刘媛,伍亚民,黄显凯.GDF10在神经病理性疼痛大鼠脊髓中的表达[J].中国病理生理杂志,2017,33(3):444-448. 被引量:4
-
10卫怡然.两片药,谋杀了他[J].中国家庭医生,2006(11S):55-55.